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Background: In patients with heart disease, the presence of a fragmented QRS complex (fQRS) on the surface
electrocardiogram (ECG) is associated with an increased risk of mortality. We sought to evaluate the prevalence
and location of fQRS before and after left ventricular assist device (LVAD) implantation and any associated risk of
mortality.
Methods and results: Twelve-lead surface ECGs before (pre-LVAD, n= 98) and after (early [b7 days], n= 96, and
late [≥30 days], n = 85, post-LVAD) LVAD implantation were evaluated for fQRS. Mortality data were gathered
via review of medical records. The prevalence of fQRS increased signiﬁcantly following LVAD implantation on
early post-LVAD ECGs (31% to 47%, p b 0.01). Patients with fQRS in the anterior territory (precordial leads V1
to V5) on late post-LVAD ECGs had decreased survival or survival to cardiac transplantation over a 30 month
follow-up period comparedwith patientswhodid not exhibit anterior fQRS (30% and 59%, respectively, p b 0.01).
Conclusions: The prevalence of fragmented QRS on 12-lead ECG increases signiﬁcantly in the anterior territory
following LVAD implantation and is associated with decreased survival.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
With advances in technology and design leading to improved
patient outcomes, left ventricular assist device (LVAD) support has
become a more widely used therapeutic option for patients with
advanced heart disease, both as a bridge to cardiac transplantation
and destination therapy [1–4]. As LVADs become increasingly utilized,
the identiﬁcation of risk factors that help predict clinical outcomes
may improve the post-operative course for these patients. To date, sev-
eral risk factors associated with adverse clinical outcomes — including
thrombocytopenia, hypoalbuminemia, low body surface area, elevated
INR, and ventricular arrhythmias— have been identiﬁed [5–8].
In prior studies of patients with heart disease, the presence of a
fragmented QRS complex (fQRS) on 12-lead surface electrocardiogram
(ECG) has been associated with an increased risk of mortality and
arrhythmic events [9–11]. The prevalence of fQRS has not been evaluat-
ed in a population of patients with LVAD. In this retrospective study, we
analyzed 12-lead surface ECGs before and after continuous-ﬂow LVAD
implantation for the prevalence and distribution of fQRS, and the asso-
ciation between fQRS and post-LVAD survival.rsity of ChicagoMedicine, 5841
2 5988; fax: +1 773 702 4666.
nd Ltd. This is an open access article un2. Methods
2.1. Patient selection
The medical records of 107 consecutive adult patients receiving a
continuous-ﬂow LVAD (HeartMate-II LVAD [Thoratec, Pleasanton, CA,
USA] or HeartWare HVAD [HeartWare, Miramar, FL, USA]) at the
University of Chicago from 2008 through 2010 were reviewed.
The HeartMate II is a second-generation continuous-ﬂow device
designed to be implanted in the muscles of the abdominal wall or
preperitoneally. It has one moving part, the rotor, which is powered
by an electromagnetic motor and spins at rates between 6000 and
15,000 rpm [1,12,13]. The HeartWare HVAD is a third-generation
continuous-ﬂow device designed to be implanted in the pericardial
space adjacent to the heart. It has one moving part, the impeller,
which spins at rates between 2400 and 3200 rpm [14,15].
For all patients, implantation of the LVADwas performed in the stan-
dard fashion by using a coring instrument to remove a portion of the left
ventricular apex, followed by securing of the LVAD inﬂow cannula
through the ventriculotomy and anastomosis of the LVAD outﬂow
graft to the ascending aorta.
2.2. ECG analysis
Archived resting twelve-lead surface ECGs (GE Marquette, GE
Healthcare, Milwaukee, WI; USA, 25 mm/s, 10 mm/mV) performed upder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
166 I.C. Thomas et al. / IJC Heart & Vasculature 7 (2015) 165–169to 30-days prior to (pre-LVAD), up to 7-days after (early post-LVAD), and
greater than 30-days after (late post-LVAD) LVAD implantation were
evaluated for the presence and distribution of fQRS. When multiple
ECGs were available, the ECG nearest to LVAD implantation within the
above speciﬁed intervals was used, unless a preponderance of electro-
magnetic artifact in the majority of leads (limb or precordial) limited
accurate interpretation. In those instances, the next available ECGwithout
artifact in themajority of leadswas used. Two investigators independent-
ly analyzed ECGs for the presence of fQRS in territories corresponding to
major coronary arteries as detailed below. For discrepancies, a third inves-
tigator adjudicated the ﬁnal determination of fQRS presence or absence.
2.3. Fragmented QRS
Criteria for identifying fQRS were adapted from Das et al. [10,16].
Fragmented QRSwith a narrow complex was deﬁned by a QRS duration
less than 120 ms and the presence of an additional R wave (R′) or
notching in the S wave in at least two contiguous leads corresponding
to a major coronary artery territory [16] (pre- and post-LVAD, Fig. 1a
and b). Fragmented QRS with a wide complex was deﬁned by a QRS
duration greater than or equal to 120 ms and the presence of more
than two R waves, more than two notches in the R wave, or more
than two notches in the S wave. In paced QRS complexes, fQRS was
deﬁned by the presence of more than two R′ waves or more than two
notches in the S wave. Findings must again have been present in at
least two contiguous leads [10]. Contiguous leads corresponding to
major coronary artery territories were designated as anterior (V1
through V5), lateral (I, aVL, and V6), and inferior (II, III, and aVF).
2.4. Survival
Mortality datawere gathered through reviewofmedical records on all
patients with available pre-LVAD and post-LVAD ECGs up to 30 monthsFig. 1. a: Pre-LVAD twelve-lead ECG showing fragmented QRS (fQRS) in leads II, III and aVF (in
QRS (fQRS) in leads V2 and V3 (anterior territory).after LVAD implantation. Causes of death were recorded when avail-
able. The primary outcome was a composite of survival or survival to
cardiac transplantation.
2.5. Statistical analysis
Comparisons of continuous variables were performed using the
Student paired t-test. Comparisons of categorical variables were
performed using the McNemar test and Fisher exact test where appro-
priate. Comparisons of survival outcomes were determined by analyses
of Kaplan–Meier plots. Two-tailed p-values of less than 0.05 were con-
sidered statistically signiﬁcant. Data are presented as mean ± standard
deviation or median [interquartile range] where appropriate.
3. Results
Of the 107 patients reviewed, seven were excluded due to the pres-
ence of a concomitant RVAD. Two patients did not have available pre-
LVAD and post-LVAD ECGs, and were also excluded. The remaining 98
patients were included in the analysis. All 98 patients had available
pre-LVAD ECGs, 96 patients had available early post-LVAD ECGs, and
85 patients had available late post-LVAD ECGs. Twelve patients did
not survive beyond 30 days.
Baseline patient characteristics are summarized in Table 1. Pre-LVAD
ECGs were performed at a median of one (1 to 3) day prior to LVAD
implantation, early post-LVAD ECGs at one (0 to 1) day after LVAD-
implantation, and late post-LVAD ECGs at 83 (38 to 201) days after
LVAD implantation.
3.1. Fragmented QRS
Theprevalence and distribution of fQRS before and after continuous-
ﬂow LVAD implantation are summarized in Table 2. There was 95.6%ferior territory). b: Post-LVAD twelve-lead ECG in same patient showing new fragmented
Table 1
Baseline patient characteristics (n = 98).
Age (years)a 57 ± 13
Male (%) 73
Female (%) 27
Ischemic cardiomyopathy (%) 49
Non-ischemic (%) 51
Pre-LVAD LVEF (%)a 18 ± 6
HeartMate II LVAD (%)b 83
HeartWare HVAD (%)c 17
Beta blocker use (%)d 30
Amiodarone use (%)d 48
Other antiarrhythmic use (%)de 16
Narrow QRS complex (%) 35
Wide QRS complex (%) 65
Ventricularly paced (%) 53
LVEF = left ventricular ejection fraction.
a Values presented as mean ± standard deviation.
b Thoratec, Pleasanton, CA.
c HeartWare International, Miramar, FL.
d During hospitalization post-LVAD implant or on discharge.
e Lidocaine or mexiletine.
Table 3
Clinical characteristics of patients with and without fragmented QRS following LVAD
implantation.a
Early post-LVAD ECG
(≤7 days) (n = 96)
Late post-LVAD ECG
(≥30 days) (n = 85)
fQRS+
(n = 46)
fQRS−
(n = 50)
fQRS+
(n = 33)
fQRS−
(n = 52)
Age (years) 56 ± 14 57 ± 12 55 ± 15 56 ± 14
Ischemic
cardiomyopathy (%)
56 41 56 37
Male (%) 74 76 79 71
LVEF (%) 16 ± 7 18 ± 7 17 ± 8 17 ± 7
HeartMate II (%) 83 84 76 89
HeartWare (%) 17 16 24 11
LVEF = left ventricular ejection fraction; HeartMate II, Thoratec, Pleasanton, CA;
HeartWare HVAD, HeartWare International, Miramar, FL.
a Differences in clinical characteristics not statistically signiﬁcant (p N 0.05).
167I.C. Thomas et al. / IJC Heart & Vasculature 7 (2015) 165–169concordance between investigators for presence of fQRS in individual
territories on independent review; the remaining 4.4% of fQRS terri-
tories were adjudicated by the third investigator. The majority of
discrepancies arose in patients with ventricular-paced QRS complexes.
On pre-LVAD ECGs, fQRS was present in at least one territory in 29%
of patients. On early post-LVAD ECGs, the prevalence of fQRS increased
signiﬁcantly, with 48% of patients having fragmentation in at least one
territory (p b 0.01). The anterior territory was the most frequently
fragmented on early post-LVAD ECGs, noted in 32% of patients and
signiﬁcantly increased compared to pre-LVAD ECGs (p b 0.001). The
prevalence of QRS fragmentation on early post-LVAD ECGs in the inferi-
or and lateral territories did not change signiﬁcantly compared to pre-
LVAD ECGs.
On late post-LVAD ECGs, there remained an increase in the preva-
lence of fQRS in at least one territory as compared to pre-operative
ECGs, though the difference was not statistically signiﬁcant (p =
0.15). The prevalence of fQRS in the anterior territory on late post-
LVAD ECGs remained signiﬁcantly increased compared to pre-LVAD
ECGs (26% versus 10%, p b 0.01).
Following LVAD implantation, a smaller proportion of patients were
noted to have fQRS on late post-LVADECG compared to early post-LVAD
ECGs.While some patients developed, and subsequently lost, fQRS post-
LVAD, when comparing early post-LVAD and late post-LVAD ECGs, the
prevalence of fQRS in at least one territory, as well as the prevalence
of fQRS in the anterior territory, did not change signiﬁcantly (p = 0.57
and 0.73, respectively).
There were no signiﬁcant differences in baseline clinical characteris-
tics between patients with fQRS in at least one territory after LVAD and
patients without fQRS after LVAD, both on early post-LVAD and late
post-LVAD ECGs (Table 3).Table 2
Prevalence and distribution of fragmented QRS by territory before and after LVAD implantation
Pre-LVAD ECG
(n = 98)
Early post-LVAD ECG
(≤7 days) (n = 96)
n (%) n (%)
fQRS (any territory) 28 (29) 46 (48)
Anterior (V1–V5) 10 (10) 31 (32)
Inferior (II, III, aVF) 19 (19) 23 (24)
Lateral (I, aVL, V6) 12 (12) 15 (16)
a Comparison of Pre-LVAD to Post-LVAD.
b Comparison of Pre-LVAD to Delayed-post LVAD.
c Comparison of Post-LVAD to Delayed-post LVAD.3.2. Survival
Mortality datawere available for all 98 patients included in the anal-
ysis; 42 (43%) survived with the LVAD or survived to cardiac transplan-
tation. The clinical outcomes and causes of death over 30 months are
summarized in Table 4. The most common cause of death included
sepsis (13%) and intracranial hemorrhage or stroke (10%); it was not
available or unknown in 18%.
Patients with an fQRS in the anterior territory (V1–V5) on late post-
LVAD ECGs had a signiﬁcantly decreased rate of survival or survival to
cardiac transplantation compared to patients without fQRS in the ante-
rior territory over 30 months (30% and 59%, respectively, p b 0.01,
Fig. 2). The causes of death were not signiﬁcantly different between
these two groups (Table 4). Patients with an fQRS in the anterior terri-
tory on pre-LVAD and early post-LVAD ECG did not have a signiﬁcantly
different rate of survival compared to their counterparts without fQRS
in the anterior territory.
For patients with fQRS in at least one territory on late post-operative
ECG, survival was not signiﬁcantly different compared to the cohort of
patients with no fQRS (p = 0.33, Fig. 3). Patients with fQRS in at least
one territory on pre-LVAD and early post-LVAD ECGs did not have a
signiﬁcantly different rate of survival compared to their counterparts
without fQRS.
Durations of QRS on pre-, early post-, and late post-LVAD ECG were
not signiﬁcantly associatedwith survival (Table 5). In patients with QRS
durations greater than or equal to 120 ms, QRS complex morphologies
and ventricular pacing were not associated with survival.
4. Discussion
Previous studies have suggested that fractionated intracardiac
electrograms are the result of delayed conduction through infarcted,
damaged, or ischemic myocardium [17–19]. Similarly, the fragmented.
pa Delayed post-LVAD ECG
(≥30 days) (n = 85)
pb pc
n (%)
b0.001 33 (39) 0.15 0.57
b0.001 22 (26) b0.01 0.73
0.45 21 (25) 0.80 1.00
0.34 9 (11) 1.00 0.51
Table 4
Survival outcomes over 30 months in patients with continuous-ﬂow LVAD.
Patients included
in survival analysis
Patients with available late
post-LVAD ECG (≥30 days)
pa
(n = 98) Fragmented
V1–V5
(n = 23)
Non-fragmented
V1–V5
(n = 62)
Alive/transplanted 43% 26% 55% 0.03b
Expired 57% 74% 45%
Sepsis 13% 13% 11% NS
ICH/stroke 10% 17% 5% 0.08
Hemorrhage 3% 4% 2% NS
LVAD
complication
6% 13% 3% 0.12
VA 1% 0% 0% NS
RHF 1% 0% 2% NS
Otherc 4% 4% 5% NS
Unknown 18% 22% 18% NS
ICH = intracranial hemorrhage; RHF = right heart failure; VA = ventricular arrhythmia.
a 2-Tailed p-value by Fisher exact test for differences between fragmented and non-
fragmented V1–V5.
b Based on combined survival and survival to transplant outcome in Kaplan–Meier
estimate.
c Includes cancer, ARDS, amiodarone toxicity, elective withdrawal of care.
Fig. 3.Kaplan–Meier survival estimate for patientswith andwithoutQRS fragmentation in
any territory (fQRS) over 30 months. Patients with fQRS in any territory on late post-
operative ECG did not have a signiﬁcantly different rate of survival or survival to cardiac
transplantation compared to patients without fQRS (p = 0.33).
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prior myocardial infarction, correlating to regional perfusion abnormal-
ities onmyocardial perfusion imaging [16]. In patientswith coronary ar-
tery disease, fQRS is predictive of increasedmortality [9], and in patients
with ischemic and nonischemic cardiomyopathy, fQRS is associated
with sudden cardiac death and ICD-treated ventricular arrhythmias
[11,20].
Patients receiving continuous-ﬂow LVAD in this analysis were
commonly found to have fQRS on pre-LVAD ECG, reﬂective of baseline
myocardial disease. However, a signiﬁcant increase in the prevalence
of fQRS was noted following LVAD implantation, both on early and
late post-LVAD ECGs. The fQRS was commonly seen in the anterior
territory (V1–V5) on post-LVAD ECGs, accounting for the majority of
all newly fragmented QRS territories following LVAD implantation.
Fragmentation of the QRS in the anterior distribution may be related
to disruption of myocardial depolarization and possible collateral
damage induced by the presence of the LVAD inﬂow cannula, which is
generally inserted into the left ventricular apex.Fig. 2.Kaplan–Meier survival estimate for patientswith andwithoutQRS fragmentation in
the anterior territory (fV1–V5) over 30 months. Patients with fV1–V5 had a signiﬁcantly
decreased rate of survival or survival to cardiac transplantation (p b 0.01).In previous studies of fQRS, it has been postulated that the increased
cardiac event rate and mortality associated with the presence of fQRS
reﬂects an association between the fQRS and signiﬁcant myocardial
disease [9,20]. In this cohort of LVAD-supported advanced heart failure
patients, fQRS was a frequent ﬁnding on pre-LVAD ECGs, but this alone
was not associated with decreased survival or survival to cardiac trans-
plantation at 30 months. However, the sustained increase in fQRS
evident on late post-LVADECGswas associatedwith decreased survival,
suggesting that even in a milieu of signiﬁcant baseline myocardial
disease, new ventricular conduction abnormalities following LVAD im-
plantation may be associated with adverse outcomes. Other alterations
in ventricular conduction, including bundle branch blocks and nonspe-
ciﬁc intraventricular conduction delays, were not associated with
decreased survival in this cohort.
Decreased survivalwas not seen in patientswith fQRS in the anterior
territory on early post-LVAD ECGs. Fewer patients had anterior territory
fQRS in the late post-LVAD period when compared to the early post-
LVAD period, suggesting that changes in ventricular depolarization
manifesting as fQRS following LVAD implantation may be transient in
some patients, and without associated mortality risk. Long-standing or
permanent alterations of conduction properties induced by LVAD im-
plantation may impart an increased risk of adverse outcomes, which
in turn may result in a decreased likelihood of survival.
It was not clear from this retrospective analysis how alterations
in ventricular conduction, as reﬂected by the presence of the fQRSTable 5
QRS complex characteristics and median survival (months) in patients with continuous-
ﬂow LVAD.
Pre-LVAD Early post-LVAD Late post-LVAD
QRS b 120 ms 10.5 [4–30] 21 [4–30] 25 [6–30]
QRS ≥ 120 ms 30 [3.5–30] 30 [3.5–30] 30 [15–30]
p 0.093 0.192 0.183
QRS morphologies
LBBB 30 [24–30] 24 [21–27] 24 [13–27]
RBBB 27 [21–28.5] 22.5 [17–28] 30 [22.5–30]
IVCD 30 [22.5–30] 30 [28.5–30] 30 [22.5–30]
V-paced 27 [2.5–30] 28.5 [2.5–30] 30 [12–30]
p 0.850 0.796 0.982
Values presented as median [interquartile range]. LBBB = left bundle branch block,
RBBB = right bundle branch block, IVCD = non-speciﬁc intraventricular conduction
delay, V-paced = ventricularly paced.
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patients. The causes of death in patients with and without fQRS in the
anterior territory were varied and did not differ signiﬁcantly between
the two groups. In previous studies of patients with heart disease, the
fQRS has been associated with an increased risk of sudden cardiac
death due to ventricular arrhythmias (VA). While none of the patients
with available late post-operative ECGs in this analysis died directly
from ventricular arrhythmias (VA), VA following LVAD-implantation
has been previously identiﬁed as a signiﬁcant risk factor for increased
rates of re-hospitalization and mortality [7,8].
In light of these ﬁndings, further study of the fQRS in a prospective
population of LVAD-supported patients is merited. The pathogenesis
of fQRS in this population is not well understood, and investigations of
fQRS development following LVAD implantation may illuminate addi-
tional details regarding the nature of conduction system andmyocardial
muscle alterations following mechanical support. As a potential prog-
nostic indicator of patient outcomes, post-LVAD fQRS may be of clinical
utility in the management of LVAD-supported patients.
5. Conclusions
The prevalence of the fragmented QRS complex (fQRS) on 12-lead
surface ECG increases signiﬁcantly following continuous-ﬂow LVAD
placement, predominantly in the anterior territory. When fQRS persists
on ECGs performed 30-days or more after LVAD implantation, there is
an associated decrease in rate of survival or survival to cardiac trans-
plantation over 30 months.
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